Research Study for Patients With Neurological Diseases Which Evaluates the Patient Experience of the MemorEM Device

Part of paid clinical trials in Atlanta, Georgia.

Sponsor
eQ8Health Corporation d/b/a CareONE Concierge
Study ID
NCT07222605
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
45 Years - 100 Years
Healthy Volunteers
Not accepted

Interventions

  • MemorEM — DEVICE
    The MemorEM device delivers 915MHz electromagnetic waves to the head via emitters in a cap worn on the head and powered by a control box and battery worn on the arm.

Study Details

Primary Objective: The primary objective of this pilot study is to gain voluntary feedback from patients with neurological diseases and their caregivers regarding their experiences using the MemorEM head device. This information may help in new designs of the MemorEM and suggest ways to increase compliance for future clinical trials and eventual commercialization. Secondary Objective: The secondary objective is to note areas of potential improvement in the progression of the subject's neurological disease and identify the potential for the MemorEM to treat neurological diseases other than Alzheimer's disease. The investigators are also interested in Alzheimer's variants like those with ApoE4 alleles (none of the participants in the 8-person pilot were Apo-E4 positive), known mutations causing early onset Alzheimer's, and Posterior Cortical Atrophy.

Key Dates

Start date
Dec 1, 2025
Status verified
Feb 2026
Primary completion
Dec 15, 2027
Completion
Dec 15, 2029

Study Design

Enrollment
1,000 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Active Comparator: Patient Experience Arm

Primary Outcome Measure

Patient and caregiver reports on device design and use [ Time Frame: Surveys will be given starting a month after beginning treatment and monthly thereafter over the course of up to two years. ]

Locations (1)

FacilityCityStateZIPSite coordinators
CareONE ConciergeAtlantaGeorgia30305-

Find similar trials in Atlanta, GA

Related Studies